DOCSLIB.ORG

Thyroid Surgery Operative Checklist

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

THYROID SURGERY OPERATIVE CHECKLIST (THYROID SYNOPTIC OPERATIVE REPORT TEMPLATE) Electronic version available on the BC SON website: http://www.bccancer.bc.ca/HPI/SON/ For a case that requires concurrent thyroid c. Benign- Goiter or Cyst 10. Adjunctive Surgical Techniques/ 14. Site of Gross Residual Cancer f. Visualized abnormal/enlarged and parathyroid surgery, please answer d. Benign- Graves Disease or Technology Utilized Present After Operation (indicate if biopsied/confirmed by questions 1 – 23 (below) and then complete Hyperthyroidism (Select all that apply) (Select all that apply) frozen section) and partially removed the Parathyroid Surgery Operative Checklist e. Inadequate FNA Biopsy(s) a. Monopolar electrocautery a. Right recurrent laryngeal nerve g. Visualized abnormal/enlarged (back of card). f. Other (please specify) b. Bipolar electrocautery b. Right esophagus (indicate if biopsied/confirmed by c. Electrothermal vessel sealing device c. Right trachea frozen section) and autotransplanted TM A. PREOPERATIVE DETAILS 6. If Thyroid Reoperation (Ligasure or equivalent) d. Right larynx h. Not identified (Select All That Apply) d. Ultrasonic vessel sealing device e. Left recurrent laryngeal nerve 1. Clinical Preamble - Dictate as a. Not applicable (Harmonic ScalpelTM or equivalent) f. Left esophagus 20. Destination and Marking of appropriate. May include details such as b. Completion thyroid lobectomy e. Recurrent laryngeal nerve g. Left trachea Parathyroid Autotransplantation patient marking, antibiotics, DVT, c. Removal central neck cancer monitoring h. Left larynx (Select all that apply) prophylaxis, etc. recurrence or persistence f. Loupes (magnifying glasses) i. Other (please specify) a. Not applicable d. Removal lateral neck cancer g. Robotics b. Right sternocleidomastoid muscle 2. Preoperative Fine Needle Aspiration recurrence or persistence h. Video assistance 15. Recurrent Laryngeal Nerve c. Right forearm (FNA) Biopsy? e. Removal central neck benign disease i. Intraoperative ultrasound Management d. Left sternocleidomastoid muscle a. Yes, image guided recurrence j. Parathyroid cryopreservation a. Right identified/preserved e. Left forearm b. Yes, not image guided f. Other (please specify) k. Other (please specify) b. Right identified/intentionally resected f. Other (please specify) c. No (go to question 5) c. Right identified /injured g. Location marked with clips 7. For Thyroid Cancer Diagnosis Only: 11. Operation Performed d. Right not identified h. Location marked with suture 3. Was the Bethesda System For Preoperative Clinical Extent of (Select all that apply) e. Left identified/preserved i. Location not marked Reporting Thyroid Cytopathology Disease Documented a. Right thyroid lobectomy f. Left identified/intentionally resected Employed? (Select all that apply) b. Right subtotal thyroidectomy g. Left identified /injured 21. Management of Central a. Yes a. Not applicable c. Right central neck dissection h. Left not identified Compartment Neck Lymph Nodes b. No b. Local (limited to thyroid or thyroid d. Right lateral neck dissection i. Not applicable (Levels VI-VII) surgical bed for reoperation) e. Left thyroid lobectomy a. Right Central Neck Dissection 4. What Was the Preoperative c. Regional (central neck lymph nodes) f. Left subtotal thyroidectomy 16. Right Superior Parathyroid Gland b. Left Central Neck Dissection Cytopathological Diagnosis? d. Regional (lateral neck lymph nodes) g. Left central neck dissection Management (select from options below) c. Bilateral Central Neck Dissection a. Non diagnostic or unsatisfactory e. Distant metastasis h. Left lateral neck dissection 17. Right Inferior Parathyroid Gland d. No Central Neck Dissection b. Benign i. Total or near total thyroidectomy Management (select from options below) c. Atypia of undetermined significance j. Isthmusectomy 18. Left Superior Parathyroid Gland B. OPERATIVE DETAILS If lateral neck dissection carried out, please or follicular lesion of undetermined k. Other (please specify) Management (select from options below) complete Lateral Neck Dissection Checklist - significance 8. Opening Narrative - May include 19. Left Inferior Parathyroid Gland SEE QUESTION 1 (BACK OF CARD) d. Follicular neoplasm or suspicious for a details such as incision type, flap If no thyroid/central neck dissection carried Management (select from options below) follicular neoplasm creation, etc. out, please complete Lateral Neck Dissection e. Suspicious for malignancy - 22. Frozen Sections Carried Out During Checklist (BACK OF CARD) Papillory Carcinoma 9. Location of Lesion(s)/Nodule(s) of a. Not applicable the Operation? f. Suspicious for malignancy - Interest b. Visualized normal (indicate if biopsied/ a. No Medullary Carcinoma (Select all that apply) 12. Gross Extrathyroidal Cancer confirmed by frozen section) and left in b. Yes g. Suspicious for malignancy - a. Right lobe +/- right central neck Extension Appreciated During situ c. What was frozen section diagnosis? Other (please specify) b. Right lateral neck Operation c. Visualized normal (indicate if biopsied/ List all diagnoses h. Malignant - Papillary Carcinoma c. Right superior mediastinum a. Yes or probable confirmed by frozen section) and i. Malignant - Medullary Carcinoma (i.e. below level of clavicle) b. No (go to question 15) removed 23. Additional Operative Details and j. Malignant - Other (please specify) d. Left lobe +/- left central neck c. Not applicable d. Visualized normal (indicate if biopsied/ Closure Narrative k. Other (please specify) e. Left lateral neck confirmed by frozen section) and May include details such as f. Left superior mediastinum 13. Gross Residual Cancer Present autotransplanted management of superior laryngeal 5. Primary Surgical Indication (ie. below level of clavicle) After Operation e. Visualized abnormal/enlarged (indicate nerve, sternotomy for goitre, drain a. FNA biopsy indeterminate or g. Both lobes +/- central neck a. Yes or probable if biopsied/confirmed by frozen section) utilization, operative blood loss, sponge suspicious for cancer h. Isthmus +/- pyramidal lobe b. No and removed and instrument counts etc. b. Malignancy- Papilla Carcinoma or other i. No specific nodule or lesion ©BC SON 2015 LATERAL NECK DISSECTION OPERATIVE CHECKLIST PARATHYROID SURGERY OPERATIVE CHECKLIST (LATERAL NECK DISSECTION SYNOPTIC OPERATIVE REPORT TEMPLATE) (PARATHYROID SYNOPTIC OPERATIVE REPORT TEMPLATE) 1. Reoperative Lateral Neck Dissection For a case that requires concurrent parathyroid and d. Total parathyroidectomy a. Visualized normal (indicate if biopsied/confirmed by a. Yes thyroid surgery, please answer questions 1–23 (below) e. Parathyroid cryopreservation frozen section) and left in situ b. No and then complete the Thyroid Surgery Operative f. Thymectomy b. Visualized abnormal (indicate if biopsied/confirmed by Checklist (back of card). g. Partial or total thyroidectomy (complete Thyroid frozen section) and partially removed 2. Management of Lateral Neck Lymph Nodes Surgery Checklist on back of card if this was carried c. Visualized abnormal (indicate if biopsied/confirmed by A. PREOPERATIVE DETAILS (Levels I-V) out) frozen section) and completely removed h. Other (please specify) (Select all that apply) 1. Clinical Preamble - Dictate as appropriate. May d. Visualised abnormal (indicate if biopsied/confirmed by a. Right lateral neck dissection include details such as marking, antibiotics, DVT QUESTIONS 8-11 SELECT FROM OPTIONS BELOW frozen section) and left in situ b. Left lateral neck dissection prophylaxis, etc. e. Not identified c. Bilateral lateral neck dissections 8. RIGHT SUPERIOR Parathyroid Evaluation 2. Surgical Indication/Preoperative Diagnosis 9. RIGHT INFERIOR Parathyroid Evaluation 20. Destination and Marking of Parathyroid 3. Lateral Neck Lymph Node Levels Dissected a. Primary Hyperparathyroidism - sporadic 10. LEFT SUPERIOR Parathyroid Evaluation Autotransplantation (select all that apply) (Select all that apply) 11. LEFT INFERIOR Parathyroid Evaluation b. Primary Hyperparathyroidism - inherited/familial a. Not applicable g. Location marked with clips a. I right f. I left c. Primary Hyperparathyroidism - lithium related b. Right forearm h. Location marked with suture b. II right g. II left d. Secondary Hyperparathyroidism a. Normal c. Explored/not identified c. Left forearm i. Other (please specify) c. III right h. III left e. Tertiary Hyperparathyroidism b. Abnormal d. Not explored/not identified d. Left sternocleidomastoid muscle d. IV right i. IV left f. Calciphytaxis e. Right sternocleidomastoid muscle e. V right j. V left g. Other (please specify) QUESTIONS 12-15 SELECT FROM TYPE A-G* BELOW f. Other (please specify) 12. RIGHT SUPERIOR Parathyroid Location 21. Adjunctive Surgical Techniques/Technology 4. Structures Identified/Visualized During 3. Reoperative Parathyroid Surgery 13. RIGHT INFERIOR Parathyroid Location Utilized (select all that apply) RIGHT Lateral Neck Dissection a. Yes, persistent disease (prior operation with failure 14. LEFT SUPERIOR Parathyroid Location a. Monopolar electrocautery (Select from options below) of PTH and/or Ca to normalize postoperatively or 15. LEFT INFERIOR Parathyroid Location b. Bipolar electrocautery 5. Structures Removed and/or Sacrificed remain normal for > 6 months) c. Electrothermal vessel sealing device During RIGHT Lateral Neck Dissection b. Yes, recurrent disease (rise in PTH and/or Ca after Type A: Adherent to the posterior thyroid parenchyma (i.e. (LigasureTM or equivalent) (Select from options below) normalization
Recommended publications
  • When Is It Minimally Invasive?

    When Is It Minimally Invasive?

    ORIGINAL ARTICLE Incision Length for Standard Thyroidectomy and Parathyroidectomy When Is It Minimally Invasive? Laurent Brunaud, MD; Rasa Zarnegar, MD; Nobuyuki Wada, MD; Philip Ituarte, PhD; Orlo H. Clark, MD; Quan-Yang Duh, MD Hypothesis: Current techniques for open conven- parathyroidectomy (PϽ.001). It was 4.1 cm for bilateral tional thyroidectomy or parathyroidectomy have evolved parathyroid exploration, but was reduced to 3.2 and 2.8 to enable a shorter incision (main proposition), and the cm for unilateral (PϽ.001) and focal (PϽ.001) explora- length of the incision is influenced by objective factors. tions, respectively. By multiple regression analysis, thy- roid specimen volume and patient body mass index were Design: Case series. independent predictors of incision length in thyroidec- tomy. Extent of exploration and resident training level Setting: University referral center. were independent predictors of incision length in parathyroidectomy. Patients and Intervention: Retrospective study of the most recent 200 primary consecutive routine thyroid and Conclusions: Current techniques for open conven- parathyroid operations (excluding neck dissections). tional thyroidectomy or parathyroidectomy have evolved to enable a shorter incision. Thyroid volume, patient body Main Outcome Measures: The length of incision was mass index, extent of the planned parathyroid explora- routinely measured with a ruler before the incision. tion, and the resident clinical training stage are impor- Univariate and multivariate analysis was performed to dis- tant variables for incision length in open operation and tinguish variables affecting length of incision. should be taken into account when minimally invasive thyroidectomy and parathyroidectomy are evaluated. Results: Mean length of the incision was 5.5 cm for to- tal thyroidectomy, 4.6 cm for lobectomy, and 3.5 cm for Arch Surg.
  • HP Layout 1-21-04 to Print

    HP Layout 1-21-04 to Print

    Winter 2004 Department of Surgery healthpoints NewYork-Presbyterian ALL THE POSSIBILITIES OF MODERN MEDICINEE DIABETES Knowledge is Power ALSO IN THIS ISSUE: in a Complex Disease Approximately 17 million people in the United States have the disease. While an estimated 11.1 million have been diagnosed, 5.9 million people remain unaware that POSITRON EMISSION they have the condition. It is the fifth leading cause of death by disease in the U.S.— TOMOGRAPHY (PET) contributing to the deaths of more than 210,000 Americans each year. And its origin Approved for the Fight remains a mystery. Against Thyroid Cancer Diabetes is a complex disease which results from the body’s inability to create or page 2 properly use insulin. A hormone produced by the pancreas, insulin helps the body convert sugar, starches, and other food into energy. If the body doesn’t make enough insulin or if the insulin doesn’t work the way it should, glucose (sugar) cannot enter into the body’s cells. Instead, ISLET CELL glucose remains in the TRANSPLANTATION bloodstream, raising the The Search for a Cure blood sugar level and for Type 1 Diabetes ultimately causing page 7 diabetes. The signs of diabetes are often subtle, which can make detection of the disease a greater AIDING THE HEART challenge. Some Medicare Approves common symptoms LVADs as Destination include excessive thirst, Diabetes strikes people of all ages, races, and genders. Therapy frequent urination, page 8 unusual weight loss, increased fatigue, slow wound healing, extreme hunger, and blurry vision. However, individuals who experience none of these signs may still have diabetes.
  • Pseudoischemic Electrocardiogram in Myasthenia Gravis with Thymoma Published Online in Wiley Interscience

    Pseudoischemic Electrocardiogram in Myasthenia Gravis with Thymoma Published Online in Wiley Interscience

    Address for correspondence: Nicola Mumoli, MD CaseShort Communication Livorno Hospital Department of Internal Medicine Viale Alfieri 36 Pseudoischemic Electrocardiogram in 57100 Livorno, Italy Myasthenia Gravis with Thymoma: [email protected] Reversibility After Thymectomy Patrizio Chiavistelli, MD, Marco Cei, MD, Giovanni Carmignani, MD, Carlo Bartolomei, MD Nicola Mumoli, MD Department of Internal Medicine, Livorno Hospital, Livorno, Italy Abnormal ST T-wave changes can be found at presentation in various noncoronary disorders; misinterpretation of these patterns as ischemic heart disease can lead to erroneous diagnosis and treatment. Here we present a case of myasthenia gravis (MG) with thymoma, in which the resting electrocardiogram (ECG) led to a misleading diagnosis of myocardial ischemia. After thymectomy, the ECG resumed a normal pattern. Myasthenia gravis is not usually considered in the differential diagnosis of conditions associated with an abnormal ECG. The combination of dysphagia, dyspnoea, ECG changes, and creatine kinase (CK) elevations may easily bring to mind an erroneous and possibly deleterious diagnosis of myocardial ischemia. Introduction did not seek medical attention. At the beginning of the The resting 12-lead electrocardiogram (ECG) remains at current year, he reported a flu-like illness, with spontaneous the center of the diagnostic pathways of acute coronary recovery, but shortly afterward he experienced dyspnea, syndromes (ACSs), either with1 or without ST segment dysphagia, and weight loss (37 kg). One month before elevation,2 because it serves as an invaluable tool for admission, he underwent fiberoptic endoscopy of the nose, both diagnosis and risk stratification. Nevertheless, as is pharynx, and larynx because of dysphonia, without any universally accepted, the predictive value of any diagnostic evidence of an active disease.
  • Studies of Thymic Function with Emphasis on the Role of the Thymus in Oncogenesist

    Studies of Thymic Function with Emphasis on the Role of the Thymus in Oncogenesist

    [CANCER RESEARCH 26 Part I, 551-574, April 1966] Studies of Thymic Function with Emphasis on the Role of the Thymus in Oncogenesist LLOYDW. LAW National Cancer Institute, Bethesda, Maryland This presentation will be concerned with 2 general topics: organ to other sites occurs with a selective seeding in spleen (a) our present knowledge of thymic structure and function, lymph nodes, and other lymphoid organs. but particularly the latter, as revealed by the results of recent For a more detailed discussion of the ontogeny of the thymus experiments in several species of animals following early thymic and its microscopic anatomy, the reader is referred to the studies ablation, and (b) consideration of the precise role of the thymus in of Smith (97) and of Ruth et al. (92). the initiation and suppression of neoplastic growths. Pertaining to Thymic Structure and Function Origin and Early Structure of the Thymus In most species the thymus is located in the upper anterior The thymus is a compound organ consisting of 3 quite different part of the chest. Exceptions are the chicken and guinea pig. cell systems: (a) lymphoid cells, (b) reticulum cells, and (c) The absolute size varies from species to species but the absolute e[)ithehal cells. The latter 2 may be referred to as the epithelial size of thymic lobules appears to be remarkably uniform in the reticulum cell complex. The thymus in mammals arises as various species, suggesting that there may be a critical limit for paired structures from the endoderm of the 3rd and 4th branchial the size of a thymic lobule.
  • Analysis of the Role of Thyroidectomy and Thymectomy in the Surgical Treatment of Secondary Hyperparathyroidism

    Analysis of the Role of Thyroidectomy and Thymectomy in the Surgical Treatment of Secondary Hyperparathyroidism

    Am J Otolaryngol 40 (2019) 67–69 Contents lists available at ScienceDirect Am J Otolaryngol journal homepage: www.elsevier.com/locate/amjoto Analysis of the role of thyroidectomy and thymectomy in the surgical ☆ treatment of secondary hyperparathyroidism T Mateus R. Soares, Graziela V. Cavalcanti, Ricardo Iwakura, Leandro J. Lucca, Elen A. Romão, ⁎ Luiz C. Conti de Freitas Division of Head and Neck Surgery, Department of Ophthalmology, Otolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School, University of Sao Paulo, Brazil ARTICLE INFO ABSTRACT Keywords: Purpose: Parathyroidectomy can be subtotal or total with an autograft for the treatment of renal hyperpar- Parathyroidectomy athyroidism. In both cases, it may be extended with bilateral thymectomy and total or partial thyroidectomy. Hyperparathyroidism Thymectomy may be recommended in combination with parathyroidectomy in order to prevent mediastinal Thymectomy recurrence. Also, the occurrence of thyroid disease observed in patients with hyperparathyroidism is poorly Thyroidectomy understood and the incidence of cancer is controversial. The aim of the present study was to report the ex- perience of a single center in the surgical treatment of renal hyperparathyroidism and to analyse the role of thyroid and thymus surgery in association with parathyroidectomy. Materials and methods: We analysed parathyroid surgery data, considering patient demographics, such as age and gender, and surgical procedure data, such as type of hyperparathyroidism, associated thyroid or thymus surgery, surgical duration and mediastinal recurrence. Histopathological results of thyroid and thymus samples were also analysed. Results: Medical records of 109 patients who underwent parathyroidectomy for secondary hyperparathyroidism were reviewed. On average, thymectomy did not have impact on time of parathyroidectomy (p = 0.62) even when thyroidectomy was included (p = 0.91).
  • Use of Dexmedetomidine in a Parturient with Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy

    Use of Dexmedetomidine in a Parturient with Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy

    PRACTICE CASE REPORT Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report Amanda L. Faulkner, MD, Eric Swanson, MD, Thomas L. McLarney, MD, Cortney Y. Lee, MD, and Annette Rebel, MD * * * † * 08/15/2018 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3yRlXg5VZA8uqNuqWFo8dRhJiNZRTFLkCeIa0nEMHM2KbYm37VRaE3A== by https://journals.lww.com/aacr from Downloaded Dexmedetomidine is a selective α2-agonist, frequently used in perioperative medicine as anes- thesia adjunct. The medication carries a Food and Drug Administration pregnancy category C Downloaded designation and is therefore rarely used for parturients undergoing nonobstetric surgery. We are reporting the use of dexmedetomidine in the anesthetic management of a parturient undergoing minimally invasive unilateral adrenalectomy for pheochromocytoma during the second trimester from https://journals.lww.com/aacr of pregnancy. Additionally, because of the multiple endocrine neoplasia type 2A constellation with diagnosis of medullary thyroid cancer, the patient underwent a total thyroidectomy 1 week after the adrenalectomy. (A&A Practice. XXX;XXX:00–00.) exmedetomidine is a selective α2-agonist, fre- CASE REPORT by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3yRlXg5VZA8uqNuqWFo8dRhJiNZRTFLkCeIa0nEMHM2KbYm37VRaE3A== quently used in perioperative medicine. It has A 34-year-old gravida 3 para 2 woman (body weight, 61 Dfound favor in this setting because of its sedative kg;
  • Cellular and Humoral Immune Alterations in Thymectomized Patients for Thymoma

    Cellular and Humoral Immune Alterations in Thymectomized Patients for Thymoma

    Cellular and humoral immune alterations in thymectomized patients for thymoma Maurizio Lalle, Mauro Minellli, Paola Tarantini, Mirella Marino, Virna Cerasoli, Francesco Facciolo, Cesare Iani, Mauro Antimi To cite this version: Maurizio Lalle, Mauro Minellli, Paola Tarantini, Mirella Marino, Virna Cerasoli, et al.. Cellular and humoral immune alterations in thymectomized patients for thymoma. Annals of Hematology, Springer Verlag, 2009, 88 (9), pp.847-853. 10.1007/s00277-008-0693-3. hal-00535026 HAL Id: hal-00535026 https://hal.archives-ouvertes.fr/hal-00535026 Submitted on 11 Nov 2010 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Ann Hematol (2009) 88:847–853 DOI 10.1007/s00277-008-0693-3 ORIGINAL ARTICLE Cellular and humoral immune alterations in thymectomized patients for thymoma Maurizio Lalle & Mauro Minellli & Paola Tarantini & Mirella Marino & Virna Cerasoli & Francesco Facciolo & Cesare Iani & Mauro Antimi Received: 1 September 2008 /Accepted: 23 December 2008 /Published online: 23 January 2009 # Springer-Verlag 2009 Abstract The aim of this study was to analyze the impact studies, a longer surveillance and a cooperative approach, of thymectomy on kinetics of the immune reconstitution in due to the rarity of the disease, are necessary to define thymoma patients.
  • Psi Technical Specs V31.Pdf

    Psi Technical Specs V31.Pdf

    AHRQ Quality Indicators Patient Safety Indicators: Technical Specifications Department of Health and Human Services Agency for Healthcare Research and Quality http://www.qualityindicators.ahrq.gov March 2003 Version 3.1 (March 12, 2007) AHRQ Quality Indicators Web Site: http://www.qualityindicators.ahrq.gov Table of Contents About the Patient Safety Indicators ............................................................................................................... 1 Patient Safety Indicators – Detailed Definitions ............................................................................................ 3 Complications of Anesthesia (PSI 1) ............................................................................................................ 3 Death in Low-Mortality DRGs (PSI 2) ........................................................................................................... 5 Decubitus Ulcer (PSI 3) ................................................................................................................................. 7 Failure to Rescue (PSI 4) .............................................................................................................................. 9 Foreign Body Left during Procedure, Secondary Diagnosis Field (PSI 5 and 21)...................................... 17 Iatrogenic Pneumothorax, Secondary Diagnosis Field (PSI 6 and 22)....................................................... 18 Selected Infections Due to Medical Care, Secondary Diagnosis Field (PSI 7 and 23) .............................
  • Pituitary Apoplexy After Subtotal Thyroidectomy In

    Pituitary Apoplexy After Subtotal Thyroidectomy In

    CASE REPORT Pituitary Apoplexy after Subtotal Thyroidectomy in an Acromegalic Patient with a Large Goiter Kazunobu Kato, Masakazu Nobori*, Yoshihiro Miyauchi, Motoki Ohnisi, Shyoji Yoshida, Shigeru Oya**, Shin Tomita** and Tomoshige Kino*** A case of pituitary apoplexy occurring after subtotal thyroidectomy in an acromegalic woman with a large adenomatous goiter is described. The patient had severe apnea because the large goiter was causing airway compression. Prior to the planned hypophysectomy, a subtotal thyroidectomy was performed to relieve tracheal stenosis. Shortly after the operation, the patient developed a headache that lasted for several days. The serum levels of growth hormoneand somatomedin-C spontaneously normalized seventeen days after this episode and have remained normal for two years. Pituitary apoplexy was thought to have caused the observed results without deterioration of the pituitary function. (Internal Medicine 35: 472-477, 1996) Key words: acromegaly, thyroid goiter, airway obstruction, diabetes mellitus Introduction and noticed enlargement of her hands. In February 1991, thirst and general fatigue developed and she consulted a local physi- Pituitary apoplexy is an uncommonevent, sometimes fatal, cian and was found to have diabetes mellitus and an abnormal but sometimes it induces complete reversal of acromegaly. It mass adjacent to the right side of the trachea, according to chest occurs in various situations, such as during the course of drug X-ray films. The patient, an unmarried desk clerk, was referred therapy for pituitary adenoma,during pregnancy, or after to us, with the complaint ofdyspnea that was moresevere lying cholecystectomy. However,there are no reports documenting down than in the sitting position. She had excessive nocturnal pituitary apoplexy after thyroidectomy.
  • Icd-9-Cm (2010)

    Icd-9-Cm (2010)

    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
  • Volume-Based Trends in Thyroid Surgery

    Volume-Based Trends in Thyroid Surgery

    ORIGINAL ARTICLE Volume-Based Trends in Thyroid Surgery Christine G. Gourin, MD; Ralph P. Tufano, MD; Arlene A. Forastiere, MD; Wayne M. Koch, MD; Timothy M. Pawlik, MD, MPH; Robert E. Bristow, MD Objective: To characterize contemporary patterns of thy- pitalization (0.44; PϽ.001), and had a lower incidence roid surgical care and variables associated with access to of recurrent laryngeal nerve injury (0.46; P=.002), hy- high-volume care. pocalcemia (0.62; PϽ.001), and thyroid cancer surgery (0.89; P=.01). After controlling for other variables, thy- Design: Cross-sectional analysis. roid surgery in 2000-2009 was associated with high- volume surgeons (OR, 1.76; PϽ.001), high-volume hos- Setting: Maryland Health Service Cost Review Com- pitals (2.93; P Ͻ .001), total thyroidectomy (2.67; mission database. PϽ.001), and neck dissection (1.28; P=.02) but was less likely to be performed for cancer (0.83; PϽ.001). Patients: Adults who underwent surgery for thyroid dis- ease in Maryland between January 1, 1990, and July 1, Conclusions: The proportion of thyroid surgical pro- 2009. cedures performed by high-volume surgeons and in high- volume hospitals increased significantly from 1990- Results: Overall, 21 270 thyroid surgical procedures were 1999 to 2000-2009, with an increase in total performed by 1034 surgeons at 51 hospitals. Proce- thyroidectomy and neck dissection. Surgeon volume was dures performed by high-volume surgeons increased from significantly associated with complication rates. Thy- 15.7% in 1990-1999 to 30.9% in 2000-2009 (odds ratio roid cancer surgery was less likely to be performed by [OR], 3.69; PϽ.001), while procedures performed at high- high-volume surgeons and in 2000-2009 despite an in- volume hospitals increased from 11.9% to 22.7% (3.46; crease in surgical cases.
  • Thyroid & Parathyroid Surgery

    Thyroid & Parathyroid Surgery

    Thyroid & Parathyroid Surgery – Frequently Asked Questions How long will the operation take? What about neck stiffness and exercises? Thyroid and parathyroid operations generally take between one to Some neck stiffness is common as a result of the prolonged three hours. extension (backward tilting) of the head under the anaesthetic. The exercises recommended will reduce it but it may last for some Will I need a general anaesthetic? weeks and require physiotherapy as well. This type of surgery requires a general anaesthetic in order to stop Will my parathyroid glands be taken out with my thyroid? muscle movement during the delicate dissection. Often the anaesthetic is supplemented by local anaesthetic or a nerve block, If you are having thyroid surgery ("thyroidectomy") then every this may result in you having a numb face and ear for 24 hours attempt is made to preserve all your parathyroid glands. Mostly afterwards. they are left in place with their blood supply attached but, if that is not technically possible, they may need to be removed and How long will my incision be and where will it be placed? transplanted into the adjacent muscle. Sometimes very small parathyroid glands are buried under the thyroid capsule and For open thyroid or parathyroid surgery the scar is a curved line in cannot be identified at operation and so get taken out with the the "collar" position, about 2cm above the collar bone. The length thyroid specimen. Transplanted parathyroid glands take between varies depending on the size of the lump removed. For minimally 6 weeks to 6 months to recover, however the body can generally invasive surgery the scar is only 2 to 3cm long and is placed on get by with just part of one parathyroid gland if necessary.